Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
124332105	12433210	5	F	20160507	20160709	20160603	20160718	EXP		DE-ACTELION-A-NJ2016-137180	ACTELION		37.00	YR	A	F	Y	0.00000		20160718		OT	DE	CO

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
124332105	12433210	1	PS	VENTAVIS	ILOPROST	1	Respiratory (inhalation)	6 DF, QD	264	DF	N				21779	6	DF	INHALATION VAPOUR, SOLUTION	QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
124332105	12433210	1	Pulmonary arterial hypertension

Outcome of event

Reactions reported

Event ID	CASEID	PT
124332105	12433210	Condition aggravated
124332105	12433210	Headache
124332105	12433210	Medical device site reaction
124332105	12433210	Product use issue
124332105	12433210	Pulmonary hypertension
124332105	12433210	Rash
124332105	12433210	Respiratory disorder
124332105	12433210	Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
124332105	12433210	1	20160507	20160620	0